文献速递消化内镜

内镜下消化道置入胶囊内镜探查小肠:一项欧洲多中心回顾性630例成人操作系列研究

Endoscopic GI placement of capsule endoscopy to investigate the small bowel: a multicenter European retrospective series of 630 procedures in adult patients.
PubMed 文献 · Gastrointest Endosc · 2024-01-24

该欧洲多中心回顾性研究纳入630例成人患者,评估内镜下消化道置入小肠胶囊内镜的技术成功率、安全性和 outcomes。技术成功率为96.8%,严重不良事件发生率为0.5%;技术成功时小肠胶囊内镜完成率为84.4%,诊断率为61.1%。胶囊递送至小肠时完成率显著高于递送至胃。

要点

  • 内镜下消化道置入小肠胶囊内镜技术成功率为96.8%,严重不良事件发生率为0.5%。
  • 技术成功时小肠胶囊内镜完成率为84.4%,诊断率为61.1%。
  • 胶囊递送至小肠时完成率显著高于递送至胃。

核心结论

  • 内镜下消化道置入小肠胶囊内镜高度可行且安全,完成率和诊断率均高。
  • 有指征时应于麻醉下进行,并将胶囊递送至十二指肠而非胃以获得更好的小肠检查结果。

研究设计与样本

  • 国际胶囊内镜研究(iCARE)组开展的多中心回顾性研究。
  • 纳入29个中心共39565例患者中630例(1.6%)年龄超过18岁、于2022年5月前接受内镜下消化道置入小肠胶囊内镜的患者。
  • 数据来自医疗记录和胶囊记录。
  • 主要终点为内镜下消化道置入操作的技术成功率。

主要发现

  • 630例患者平均年龄62.5岁,女性占55.9%。
  • 内镜下消化道置入技术成功610例(96.8%)。
  • 麻醉(中度至深度镇静或全身麻醉)和操作量中等或高的中心是技术成功的独立因素。
  • 3例患者(0.5%)发生严重不良事件。
  • 技术成功时,小肠胶囊内镜完成率为84.4%,诊断率为61.1%。

临床怎么用

  • 作者认为,有指征时内镜下消化道置入小肠胶囊内镜应在麻醉下进行。
  • 作者认为,胶囊应递送至十二指肠而非胃以获得更好的小肠检查结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Small-bowel (SB) capsule endoscopy (CE) is a first-line procedure for exploring the SB. Endoscopic GI PlacemenT (EGIPT) of SB CE is sometimes necessary. Although experience with EGIPT is considerable in pediatric populations, we aimed to describe the safety, efficacy, and outcomes of EGIPT of SB CE in adult patients. METHODS: The international CApsule endoscopy REsearch (iCARE) group set up a retrospective multicenter study. Patients over age 18 years who underwent EGIPT of SB CE before May 2022 were included. Data were collected from medical records and capsule recordings. The primary endpoint was the technical success rate of the EGIPT procedures. RESULTS: Of 39,565 patients from 29 centers, 630 (1.6%) were included (mean age, 62.5 years; 55.9% women). The technical success of EGIPT was achieved in 610 procedures (96.8%). Anesthesia (moderate to deep sedation or general anesthesia) and centers with intermediate or high procedure loads were independent factors of technical success. Severe adverse events occurred in 3 patients (.5%). When technically successful, EGIPT was associated with a high SB CE completion rate (84.4%) and with a substantial diagnostic yield (61.1%). The completion rate was significantly higher when the capsule was delivered in the SB compared with when it was delivered in the stomach. CONCLUSIONS: EGIPT of SB CE is highly feasible and safe, with a high completion rate and diagnostic yield. When indicated, it should be performed with patients under anesthesia, and the capsule should be delivered in the duodenum rather than the stomach for better SB examination outcomes.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ouazana S, Baltes P, Toth E, et al. Endoscopic GI placement of capsule endoscopy to investigate the small bowel: a multicenter European retrospective series of 630 procedures in adult patients. Gastrointest Endosc. 2024. PMID: 38272273. doi:10.1016/j.gie.2024.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。